Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

Q13822

- ENPP2_HUMAN

UniProt

Q13822 - ENPP2_HUMAN

(max 400 entries)x

Your basket is currently empty.

Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)

Protein

Ectonucleotide pyrophosphatase/phosphodiesterase family member 2

Gene

ENPP2

Organism
Homo sapiens (Human)
Status
Reviewed - Annotation score: 5 out of 5- Experimental evidence at protein leveli

Functioni

Hydrolyzes lysophospholipids to produce lysophosphatidic acid (LPA) in extracellular fluids. Major substrate is lysophosphatidylcholine. Also can act on sphingosylphosphphorylcholine producing sphingosine-1-phosphate, a modulator of cell motility. Can hydrolyze, in vitro, bis-pNPP, to some extent pNP-TMP, and barely ATP. Involved in several motility-related processes such as angiogenesis and neurite outgrowth. Acts as an angiogenic factor by stimulating migration of smooth muscle cells and microtubule formation. Stimulates migration of melanoma cells, probably via a pertussis toxin-sensitive G protein. May have a role in induction of parturition. Possible involvement in cell proliferation and adipose tissue development. Tumor cell motility-stimulating factor.3 Publications

Catalytic activityi

1-alkyl-sn-glycero-3-phosphoethanolamine + H2O = 1-alkyl-sn-glycerol 3-phosphate + ethanolamine.1 Publication

Cofactori

Protein has several cofactor binding sites:
  • Zn2+By similarityNote: Binds 2 Zn(2+) ions per subunit.By similarity
  • Ca2+By similarityNote: Binds 1 Ca(2+) ion per subunit.By similarity

Enzyme regulationi

Inhibited by lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P). Inhibited by EDTA and EGTA (Probable).3 Publications

Kineticsi

  1. KM=0.5 mM for 16:0-LPC (at pH 8.5)2 Publications
  2. KM=5.5 mM for pNP-TMP (at pH 8.5)2 Publications
  3. KM=11.3 mM for pNppp (isoform 1)2 Publications
  4. KM=5.7 mM for pNppp (isoform 2)2 Publications
  5. KM=19.8 mM for pNppp (isoform 3)2 Publications

Vmax=1.9 nmol/min/µg enzyme with pNppp as substrate (isoform 1)2 Publications

Vmax=0.67 nmol/min/µg enzyme with pNppp as substrate (isoform 2)2 Publications

Vmax=1.6 nmol/min/µg enzyme with pNppp as substrate (isoform 3)2 Publications

pH dependencei

Optimum pH is 9.0 (isoform 1), 8.0 (isoform 3). Isoform 1 is less sensitive to pH. Isoform 1, isoform 2 and isoform 3 all retain some activity at pH 9.5.2 Publications

Temperature dependencei

Isoform 1 and isoform 3 are active from 45 to 60 degrees Celsius.2 Publications

Sites

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Metal bindingi172 – 1721Zinc 1; catalyticBy similarity
Active sitei210 – 2101NucleophileBy similarity
Metal bindingi210 – 2101Zinc 1; catalyticBy similarity
Binding sitei231 – 2311SubstrateBy similarity
Binding sitei307 – 3071SubstrateBy similarity
Metal bindingi312 – 3121Zinc 2; catalyticBy similarity
Metal bindingi316 – 3161Zinc 2; catalyticBy similarity
Metal bindingi316 – 3161Zinc 2; via tele nitrogen; catalyticBy similarity
Metal bindingi359 – 3591Zinc 1; catalyticBy similarity
Metal bindingi360 – 3601Zinc 1; catalyticBy similarity
Metal bindingi360 – 3601Zinc 1; via tele nitrogen; catalyticBy similarity
Metal bindingi475 – 4751Zinc 2; catalyticBy similarity
Metal bindingi475 – 4751Zinc 2; via tele nitrogen; catalyticBy similarity
Metal bindingi740 – 7401CalciumBy similarity
Metal bindingi744 – 7441CalciumBy similarity
Metal bindingi746 – 7461Calcium; via carbonyl oxygenBy similarity
Metal bindingi748 – 7481CalciumBy similarity
Sitei853 – 8531Essential for catalytic activityBy similarity

GO - Molecular functioni

  1. alkylglycerophosphoethanolamine phosphodiesterase activity Source: UniProtKB-EC
  2. calcium ion binding Source: UniProtKB
  3. hydrolase activity Source: UniProtKB
  4. lysophospholipase activity Source: UniProtKB
  5. nucleic acid binding Source: InterPro
  6. nucleotide diphosphatase activity Source: ProtInc
  7. phosphodiesterase I activity Source: ProtInc
  8. polysaccharide binding Source: InterPro
  9. scavenger receptor activity Source: InterPro
  10. transcription factor binding Source: ProtInc
  11. zinc ion binding Source: UniProtKB

GO - Biological processi

  1. cellular component movement Source: ProtInc
  2. chemotaxis Source: UniProtKB
  3. G-protein coupled receptor signaling pathway Source: ProtInc
  4. immune response Source: InterPro
  5. nucleic acid phosphodiester bond hydrolysis Source: GOC
  6. phosphate-containing compound metabolic process Source: ProtInc
  7. phosphatidylcholine catabolic process Source: UniProtKB
  8. phospholipid catabolic process Source: UniProt
  9. regulation of cell migration Source: UniProtKB
Complete GO annotation...

Keywords - Molecular functioni

Hydrolase

Keywords - Biological processi

Chemotaxis, Lipid degradation, Lipid metabolism

Keywords - Ligandi

Calcium, Metal-binding, Zinc

Enzyme and pathway databases

SABIO-RKQ13822.

Names & Taxonomyi

Protein namesi
Recommended name:
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (EC:3.1.4.39)
Short name:
E-NPP 2
Alternative name(s):
Autotaxin
Extracellular lysophospholipase D
Short name:
LysoPLD
Gene namesi
Name:ENPP2
Synonyms:ATX, PDNP2
OrganismiHomo sapiens (Human)
Taxonomic identifieri9606 [NCBI]
Taxonomic lineageiEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo
ProteomesiUP000005640: Chromosome 8

Organism-specific databases

HGNCiHGNC:3357. ENPP2.

Subcellular locationi

Secreted 1 Publication
Note: Secreted by most body fluids including serum and CSF. Also by adipocytes and numerous cancer cells.

GO - Cellular componenti

  1. extracellular space Source: UniProtKB
  2. integral component of plasma membrane Source: ProtInc
  3. plasma membrane Source: ProtInc
Complete GO annotation...

Keywords - Cellular componenti

Secreted

Pathology & Biotechi

Mutagenesis

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Mutagenesisi170 – 1701S → E: Reduces lysophospholipase activity by about 70%.
Mutagenesisi210 – 2101T → A: Loss of lysophospholipase activity. 1 Publication
Mutagenesisi211 – 2111F → Y: Reduces lysophospholipase activity by about 70%. 1 Publication
Mutagenesisi218 – 2181A → V: Reduces lysophospholipase activity by about 50%. 1 Publication
Mutagenesisi231 – 2311N → A: Strongly reduced lysophospholipase activity. 1 Publication
Mutagenesisi307 – 3071Y → Q: Reduces lysophospholipase activity by about 70%. 1 Publication

Keywords - Diseasei

Obesity

Organism-specific databases

PharmGKBiPA27792.

PTM / Processingi

Molecule processing

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Signal peptidei1 – 2727By similarityAdd
BLAST
Propeptidei28 – 358Removed by furin2 PublicationsPRO_0000281649
Chaini36 – 863828Ectonucleotide pyrophosphatase/phosphodiesterase family member 2PRO_0000188567Add
BLAST

Amino acid modifications

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Glycosylationi54 – 541N-linked (GlcNAc...)Sequence Analysis
Disulfide bondi59 ↔ 76PROSITE-ProRule annotation
Disulfide bondi63 ↔ 94PROSITE-ProRule annotation
Disulfide bondi74 ↔ 87PROSITE-ProRule annotation
Disulfide bondi80 ↔ 86PROSITE-ProRule annotation
Disulfide bondi103 ↔ 120PROSITE-ProRule annotation
Disulfide bondi108 ↔ 138PROSITE-ProRule annotation
Disulfide bondi118 ↔ 131PROSITE-ProRule annotation
Disulfide bondi124 ↔ 130PROSITE-ProRule annotation
Disulfide bondi149 ↔ 195PROSITE-ProRule annotation
Disulfide bondi157 ↔ 351PROSITE-ProRule annotation
Disulfide bondi367 ↔ 469PROSITE-ProRule annotation
Glycosylationi411 – 4111N-linked (GlcNAc...)Sequence Analysis
Disulfide bondi414 ↔ 806PROSITE-ProRule annotation
Glycosylationi525 – 5251N-linked (GlcNAc...)Sequence Analysis
Disulfide bondi567 ↔ 667PROSITE-ProRule annotation
Disulfide bondi569 ↔ 652PROSITE-ProRule annotation
Disulfide bondi775 ↔ 785PROSITE-ProRule annotation
Glycosylationi807 – 8071N-linked (GlcNAc...)Sequence Analysis

Post-translational modificationi

N-glycosylation, but not furin-cleavage, plays a critical role on secretion and on lysoPLD activity.By similarity

Keywords - PTMi

Cleavage on pair of basic residues, Disulfide bond, Glycoprotein

Proteomic databases

PaxDbiQ13822.
PRIDEiQ13822.

PTM databases

PhosphoSiteiQ13822.

Expressioni

Tissue specificityi

Predominantly expressed in brain, placenta, ovary, and small intestine. Expressed in a number of carcinomas such as hepatocellular and prostate carcinoma, neuroblastoma and non-small-cell lung cancer. Expressed in body fluids such as plasma, cerebral spinal fluid (CSF), saliva, follicular and amniotic fluids. Not detected in leukocytes. Isoform 1 is more highly expressed in peripheral tissues than in the central nervous system (CNS). Adipocytes only express isoform 1. Isoform 3 is more highly expressed in the brain than in peripheral tissues.3 Publications

Inductioni

Up-regulated in massively obese subjects with glucose intolerance, and during adipogenesis.1 Publication

Gene expression databases

BgeeiQ13822.
CleanExiHS_ENPP2.
ExpressionAtlasiQ13822. baseline and differential.
GenevestigatoriQ13822.

Organism-specific databases

HPAiHPA023700.

Interactioni

Protein-protein interaction databases

BioGridi111194. 2 interactions.
IntActiQ13822. 2 interactions.
MINTiMINT-7969086.

Structurei

3D structure databases

ProteinModelPortaliQ13822.
SMRiQ13822. Positions 52-860.
ModBaseiSearch...
MobiDBiSearch...

Family & Domainsi

Domains and Repeats

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Domaini55 – 9844SMB 1PROSITE-ProRule annotationAdd
BLAST
Domaini99 – 14345SMB 2PROSITE-ProRule annotationAdd
BLAST

Region

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Regioni211 – 2144Substrate bindingBy similarity
Regioni244 – 25512Substrate bindingBy similarityAdd
BLAST
Regioni830 – 85122Required for secretionBy similarityAdd
BLAST

Motif

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Motifi127 – 1293Cell attachment siteSequence Analysis

Sequence similaritiesi

Contains 2 SMB (somatomedin-B) domains.Curated

Keywords - Domaini

Repeat, Signal

Phylogenomic databases

eggNOGiCOG1524.
GeneTreeiENSGT00760000119157.
HOVERGENiHBG051484.
InParanoidiQ13822.
KOiK01122.
OMAiGYGPTFK.
OrthoDBiEOG7XM2X4.
PhylomeDBiQ13822.
TreeFamiTF330032.

Family and domain databases

Gene3Di3.40.570.10. 1 hit.
3.40.720.10. 1 hit.
InterProiIPR017849. Alkaline_Pase-like_a/b/a.
IPR017850. Alkaline_phosphatase_core.
IPR001604. DNA/RNA_non-sp_Endonuclease.
IPR024873. E-NPP.
IPR020821. Extracellular_endonuc_su_A.
IPR002591. Phosphodiest/P_Trfase.
IPR020436. Somatomedin_B_chordata.
IPR001212. Somatomedin_B_dom.
[Graphical view]
PANTHERiPTHR10151. PTHR10151. 1 hit.
PfamiPF01223. Endonuclease_NS. 1 hit.
PF01663. Phosphodiest. 2 hits.
PF01033. Somatomedin_B. 2 hits.
[Graphical view]
PRINTSiPR00022. SOMATOMEDINB.
SMARTiSM00892. Endonuclease_NS. 1 hit.
SM00477. NUC. 1 hit.
SM00201. SO. 2 hits.
[Graphical view]
SUPFAMiSSF53649. SSF53649. 1 hit.
PROSITEiPS00524. SMB_1. 2 hits.
PS50958. SMB_2. 2 hits.
[Graphical view]

Sequences (3)i

Sequence statusi: Complete.

Sequence processingi: The displayed sequence is further processed into a mature form.

This entry describes 3 isoformsi produced by alternative splicing. Align

Isoform 1 (identifier: Q13822-1) [UniParc]FASTAAdd to Basket

Also known as: ATXter, Beta

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.

« Hide

        10         20         30         40         50
MARRSSFQSC QIISLFTFAV GVNICLGFTA HRIKRAEGWE EGPPTVLSDS
60 70 80 90 100
PWTNISGSCK GRCFELQEAG PPDCRCDNLC KSYTSCCHDF DELCLKTARG
110 120 130 140 150
WECTKDRCGE VRNEENACHC SEDCLARGDC CTNYQVVCKG ESHWVDDDCE
160 170 180 190 200
EIKAAECPAG FVRPPLIIFS VDGFRASYMK KGSKVMPNIE KLRSCGTHSP
210 220 230 240 250
YMRPVYPTKT FPNLYTLATG LYPESHGIVG NSMYDPVFDA TFHLRGREKF
260 270 280 290 300
NHRWWGGQPL WITATKQGVK AGTFFWSVVI PHERRILTIL QWLTLPDHER
310 320 330 340 350
PSVYAFYSEQ PDFSGHKYGP FGPEMTNPLR EIDKIVGQLM DGLKQLKLHR
360 370 380 390 400
CVNVIFVGDH GMEDVTCDRT EFLSNYLTNV DDITLVPGTL GRIRSKFSNN
410 420 430 440 450
AKYDPKAIIA NLTCKKPDQH FKPYLKQHLP KRLHYANNRR IEDIHLLVER
460 470 480 490 500
RWHVARKPLD VYKKPSGKCF FQGDHGFDNK VNSMQTVFVG YGSTFKYKTK
510 520 530 540 550
VPPFENIELY NVMCDLLGLK PAPNNGTHGS LNHLLRTNTF RPTMPEEVTR
560 570 580 590 600
PNYPGIMYLQ SDFDLGCTCD DKVEPKNKLD ELNKRLHTKG STEERHLLYG
610 620 630 640 650
RPAVLYRTRY DILYHTDFES GYSEIFLMPL WTSYTVSKQA EVSSVPDHLT
660 670 680 690 700
SCVRPDVRVS PSFSQNCLAY KNDKQMSYGF LFPPYLSSSP EAKYDAFLVT
710 720 730 740 750
NMVPMYPAFK RVWNYFQRVL VKKYASERNG VNVISGPIFD YDYDGLHDTE
760 770 780 790 800
DKIKQYVEGS SIPVPTHYYS IITSCLDFTQ PADKCDGPLS VSSFILPHRP
810 820 830 840 850
DNEESCNSSE DESKWVEELM KMHTARVRDI EHLTSLDFFR KTSRSYPEIL
860
TLKTYLHTYE SEI
Length:863
Mass (Da):98,994
Last modified:March 2, 2010 - v3
Checksum:i94A7A2B3701F0993
GO
Isoform 2 (identifier: Q13822-2) [UniParc]FASTAAdd to Basket

Also known as: ATXmel, Alpha

The sequence of this isoform differs from the canonical sequence as follows:
     324-324: E → EESSYGSPFTPAKRPKRKVAPKRRQERPVAPPKKRRRKIHRMDHYAAETRQDK

Show »
Length:915
Mass (Da):105,201
Checksum:i30C7CB1E60101B75
GO
Isoform 3 (identifier: Q13822-3) [UniParc]FASTAAdd to Basket

Also known as: Gamma

The sequence of this isoform differs from the canonical sequence as follows:
     593-593: E → EAETRKFRGSRNENKENINGNFEPRK

Show »
Length:888
Mass (Da):101,968
Checksum:i17A8986783028C4D
GO

Experimental Info

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Sequence conflicti23 – 231N → S in AAA64785. (PubMed:7982964)Curated
Sequence conflicti23 – 231N → S in ABW38316. (PubMed:18175805)Curated
Sequence conflicti73 – 731D → H in BAA08260. (PubMed:8586446)Curated
Sequence conflicti100 – 1001G → A in AAB00855. (PubMed:8579579)Curated
Sequence conflicti291 – 2911Q → R in AAA64785. (PubMed:7982964)Curated
Sequence conflicti291 – 2911Q → R in ABW38316. (PubMed:18175805)Curated
Sequence conflicti349 – 3491H → R in AAA64785. (PubMed:7982964)Curated
Sequence conflicti349 – 3491H → R in ABW38316. (PubMed:18175805)Curated
Sequence conflicti457 – 4571K → P AA sequence (PubMed:1733949)Curated
Sequence conflicti501 – 5011V → S AA sequence (PubMed:1733949)Curated
Sequence conflicti508 – 5081E → N AA sequence (PubMed:1733949)Curated
Sequence conflicti554 – 5541P → L AA sequence (PubMed:1733949)Curated
Sequence conflicti629 – 6291P → L in AAA64785. (PubMed:7982964)Curated
Sequence conflicti629 – 6291P → L in ABW38316. (PubMed:18175805)Curated
Sequence conflicti644 – 6441S → R in BAA08260. (PubMed:8586446)Curated
Sequence conflicti703 – 7031V → A in BAA08260. (PubMed:8586446)Curated
Sequence conflicti769 – 7691Y → H in BAA08260. (PubMed:8586446)Curated
Isoform 3 (identifier: Q13822-3)
Sequence conflicti23 – 231N → S in ABW38316. (PubMed:18175805)Curated
Sequence conflicti291 – 2911Q → R in ABW38316. (PubMed:18175805)Curated
Sequence conflicti349 – 3491H → R in ABW38316. (PubMed:18175805)Curated
Sequence conflicti493 – 4931S → P in ABW38316. (PubMed:18175805)Curated
Sequence conflicti599 – 5991F → Y in ABW38316. (PubMed:18175805)Curated
Sequence conflicti602 – 6021S → T in ABW38316. (PubMed:18175805)Curated
Sequence conflicti654 – 6541P → L in ABW38316. (PubMed:18175805)Curated

Natural variant

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Natural varianti493 – 4931S → P.7 Publications
Corresponds to variant rs10283100 [ dbSNP | Ensembl ].
VAR_060469
Natural varianti577 – 5771N → S.
Corresponds to variant rs2289886 [ dbSNP | Ensembl ].
VAR_057472
Natural varianti726 – 7261S → L.
Corresponds to variant rs16892767 [ dbSNP | Ensembl ].
VAR_057473

Alternative sequence

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Alternative sequencei324 – 3241E → EESSYGSPFTPAKRPKRKVA PKRRQERPVAPPKKRRRKIH RMDHYAAETRQDK in isoform 2. 2 PublicationsVSP_006750
Alternative sequencei593 – 5931E → EAETRKFRGSRNENKENING NFEPRK in isoform 3. 1 PublicationVSP_036398

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
L35594 mRNA. Translation: AAA64785.1.
D45421 mRNA. Translation: BAA08260.1.
D45914 Genomic DNA. Translation: BAA08342.1.
L46720 mRNA. Translation: AAB00855.1.
EU131011 mRNA. Translation: ABW38316.2.
AC099818 Genomic DNA. No translation available.
AC107960 Genomic DNA. No translation available.
BC034961 mRNA. Translation: AAH34961.1.
CCDSiCCDS34936.1. [Q13822-1]
CCDS47914.1. [Q13822-3]
CCDS6329.1. [Q13822-2]
PIRiA55144.
RefSeqiNP_001035181.1. NM_001040092.2. [Q13822-1]
NP_001124335.1. NM_001130863.2. [Q13822-3]
NP_006200.3. NM_006209.4. [Q13822-2]
UniGeneiHs.190977.

Genome annotation databases

EnsembliENST00000075322; ENSP00000075322; ENSG00000136960. [Q13822-1]
ENST00000259486; ENSP00000259486; ENSG00000136960. [Q13822-2]
ENST00000522826; ENSP00000428291; ENSG00000136960. [Q13822-3]
GeneIDi5168.
KEGGihsa:5168.
UCSCiuc003yos.2. human. [Q13822-2]
uc003yot.2. human. [Q13822-1]

Polymorphism databases

DMDMi290457674.

Keywords - Coding sequence diversityi

Alternative splicing, Polymorphism

Cross-referencesi

Web resourcesi

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
L35594 mRNA. Translation: AAA64785.1 .
D45421 mRNA. Translation: BAA08260.1 .
D45914 Genomic DNA. Translation: BAA08342.1 .
L46720 mRNA. Translation: AAB00855.1 .
EU131011 mRNA. Translation: ABW38316.2 .
AC099818 Genomic DNA. No translation available.
AC107960 Genomic DNA. No translation available.
BC034961 mRNA. Translation: AAH34961.1 .
CCDSi CCDS34936.1. [Q13822-1 ]
CCDS47914.1. [Q13822-3 ]
CCDS6329.1. [Q13822-2 ]
PIRi A55144.
RefSeqi NP_001035181.1. NM_001040092.2. [Q13822-1 ]
NP_001124335.1. NM_001130863.2. [Q13822-3 ]
NP_006200.3. NM_006209.4. [Q13822-2 ]
UniGenei Hs.190977.

3D structure databases

ProteinModelPortali Q13822.
SMRi Q13822. Positions 52-860.
ModBasei Search...
MobiDBi Search...

Protein-protein interaction databases

BioGridi 111194. 2 interactions.
IntActi Q13822. 2 interactions.
MINTi MINT-7969086.

Chemistry

BindingDBi Q13822.
ChEMBLi CHEMBL3691.

PTM databases

PhosphoSitei Q13822.

Polymorphism databases

DMDMi 290457674.

Proteomic databases

PaxDbi Q13822.
PRIDEi Q13822.

Protocols and materials databases

DNASUi 5168.
Structural Biology Knowledgebase Search...

Genome annotation databases

Ensembli ENST00000075322 ; ENSP00000075322 ; ENSG00000136960 . [Q13822-1 ]
ENST00000259486 ; ENSP00000259486 ; ENSG00000136960 . [Q13822-2 ]
ENST00000522826 ; ENSP00000428291 ; ENSG00000136960 . [Q13822-3 ]
GeneIDi 5168.
KEGGi hsa:5168.
UCSCi uc003yos.2. human. [Q13822-2 ]
uc003yot.2. human. [Q13822-1 ]

Organism-specific databases

CTDi 5168.
GeneCardsi GC08M120569.
H-InvDB HIX0025550.
HGNCi HGNC:3357. ENPP2.
HPAi HPA023700.
MIMi 601060. gene.
neXtProti NX_Q13822.
PharmGKBi PA27792.
GenAtlasi Search...

Phylogenomic databases

eggNOGi COG1524.
GeneTreei ENSGT00760000119157.
HOVERGENi HBG051484.
InParanoidi Q13822.
KOi K01122.
OMAi GYGPTFK.
OrthoDBi EOG7XM2X4.
PhylomeDBi Q13822.
TreeFami TF330032.

Enzyme and pathway databases

SABIO-RK Q13822.

Miscellaneous databases

ChiTaRSi ENPP2. human.
GeneWikii Autotaxin.
GenomeRNAii 5168.
NextBioi 19994.
PROi Q13822.
SOURCEi Search...

Gene expression databases

Bgeei Q13822.
CleanExi HS_ENPP2.
ExpressionAtlasi Q13822. baseline and differential.
Genevestigatori Q13822.

Family and domain databases

Gene3Di 3.40.570.10. 1 hit.
3.40.720.10. 1 hit.
InterProi IPR017849. Alkaline_Pase-like_a/b/a.
IPR017850. Alkaline_phosphatase_core.
IPR001604. DNA/RNA_non-sp_Endonuclease.
IPR024873. E-NPP.
IPR020821. Extracellular_endonuc_su_A.
IPR002591. Phosphodiest/P_Trfase.
IPR020436. Somatomedin_B_chordata.
IPR001212. Somatomedin_B_dom.
[Graphical view ]
PANTHERi PTHR10151. PTHR10151. 1 hit.
Pfami PF01223. Endonuclease_NS. 1 hit.
PF01663. Phosphodiest. 2 hits.
PF01033. Somatomedin_B. 2 hits.
[Graphical view ]
PRINTSi PR00022. SOMATOMEDINB.
SMARTi SM00892. Endonuclease_NS. 1 hit.
SM00477. NUC. 1 hit.
SM00201. SO. 2 hits.
[Graphical view ]
SUPFAMi SSF53649. SSF53649. 1 hit.
PROSITEi PS00524. SMB_1. 2 hits.
PS50958. SMB_2. 2 hits.
[Graphical view ]
ProtoNeti Search...

Publicationsi

« Hide 'large scale' publications
  1. "cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases."
    Murata J., Lee H.Y., Clair T., Krutzsch H.C., Arestad A.A., Sobel M.E., Liotta L.A., Stracke M.L.
    J. Biol. Chem. 269:30479-30484(1994) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), PARTIAL PROTEIN SEQUENCE, CHARACTERIZATION, VARIANT PRO-493.
    Tissue: Melanoma.
  2. "Molecular cloning and chromosomal assignment of the human brain-type phosphodiesterase I/nucleotide pyrophosphatase gene (PDNP2)."
    Kawagoe H., Soma O., Goji J., Nishimura N., Narita M., Inazawa J., Nakamura H., Sano K.
    Genomics 30:380-384(1995) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-45, TISSUE SPECIFICITY, VARIANT PRO-493.
  3. "Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells."
    Lee H.Y., Murata J., Clair T., Polymeropoulos M.H., Torres R., Manrow R.E., Liotta L.A., Stracke M.L.
    Biochem. Biophys. Res. Commun. 218:714-719(1996) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, VARIANT PRO-493.
    Tissue: Teratocarcinoma.
  4. Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, ENZYME REGULATION, VARIANT PRO-493.
  5. "Murine and human autotaxin alpha, beta, and gamma isoforms: gene organization, tissue distribution, and biochemical characterization."
    Giganti A., Rodriguez M., Fould B., Moulharat N., Coge F., Chomarat P., Galizzi J.-P., Valet P., Saulnier-Blache J.-S., Boutin J.A., Ferry G.
    J. Biol. Chem. 283:7776-7789(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), PROTEIN SEQUENCE OF 36-42 AND 49-54, ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY, VARIANT PRO-493.
    Tissue: Brain and Melanoma.
  6. "DNA sequence and analysis of human chromosome 8."
    Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S., Asakawa T.
    , Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P., Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H., Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N., Lander E.S.
    Nature 439:331-335(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
  7. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT PRO-493.
    Tissue: Testis.
  8. "Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase."
    Tokumura A., Majima E., Kariya Y., Tominaga K., Kogure K., Yasuda K., Fukuzawa K.
    J. Biol. Chem. 277:39436-39442(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: PROTEIN SEQUENCE OF 36-49; 318-330; 335-344; 440-450 AND 854-863, IDENTIFICATION, BIOPHYSICOCHEMICAL PROPERTIES.
  9. "Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein."
    Stracke M.L., Krutzsch H.C., Unsworth E.J., Aarestad A., Cioce V., Schiffmann E., Liotta L.A.
    J. Biol. Chem. 267:2524-2529(1992) [PubMed] [Europe PMC] [Abstract]
    Cited for: PROTEIN SEQUENCE OF 256-266; 370-392; 457-463; 481-496; 501-510; 545-554; 639-643; 706-710 AND 829-840, FUNCTION, VARIANT PRO-493.
    Tissue: Melanoma.
  10. "Autotaxin (NPP-2), a metastasis-enhancing mitogen, is an angiogenic factor."
    Nam S.W., Clair T., Kim Y.S., McMarlin A., Schiffmann E., Liotta L.A., Stracke M.L.
    Cancer Res. 61:6938-6944(2001) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN ANGIOGENESIS.
  11. "Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression."
    Boucher J., Quilliot D., Pradere J.P., Simon M.F., Gres S., Guigne C., Prevot D., Ferry G., Boutin J.A., Carpene C., Valet P., Saulnier-Blache J.S.
    Diabetologia 48:569-577(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: INDUCTION, POSSIBLE FUNCTION IN OBESITY.
  12. Cited for: FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, MUTAGENESIS OF THR-210; PHE-211; ALA-218; ASN-231 AND TYR-307.

Entry informationi

Entry nameiENPP2_HUMAN
AccessioniPrimary (citable) accession number: Q13822
Secondary accession number(s): A8UHA1
, E9PHP7, Q13827, Q14555, Q15117, Q9UCQ8, Q9UCR0, Q9UCR1, Q9UCR2, Q9UCR3, Q9UCR4
Entry historyi
Integrated into UniProtKB/Swiss-Prot: September 19, 2002
Last sequence update: March 2, 2010
Last modified: November 26, 2014
This is version 139 of the entry and version 3 of the sequence. [Complete history]
Entry statusiReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Miscellaneousi

Keywords - Technical termi

Complete proteome, Direct protein sequencing, Reference proteome

Documents

  1. Human chromosome 8
    Human chromosome 8: entries, gene names and cross-references to MIM
  2. Human entries with polymorphisms or disease mutations
    List of human entries with polymorphisms or disease mutations
  3. Human polymorphisms and disease mutations
    Index of human polymorphisms and disease mutations
  4. MIM cross-references
    Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot
  5. SIMILARITY comments
    Index of protein domains and families

External Data

Dasty 3